SGLT2 inhibitors therapy protects glucotoxicity-induced β-cell failure in a mouse model of human K(ATP)-induced diabetes through mitigation of oxidative and ER stress

por Shyr, Zeenat A., Yan, Zihan, Ustione, Alessandro, Egan, Erin M., Remedi, Maria S.
Publicado 2022